These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of daunorubicin and cytarabine on cell line NB4].
    Author: Luo ZG, Zhong L, Chen FY, Wang HR, Ouyang RR.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202.
    Abstract:
    OBJECTIVE: To explore whether daunorubicin (DNR) combined with cytosine arabinoside (Ara-C) and DNR alone have similar effect on acute promyelocytic leukemia (APL) cell line NB4 and acute myeloblastic leukemia cell line HL-60 in vitro. METHODS: Cell morphology, cells viability, and cell apoptosis (Annexin-V by flow cytometry assay) were analysed. RESULTS: After incubation with DNR plus Ara-C for 24 hours,NB4 cell viability [(36.75 +/- 3.82)%] (n = 6) and cell apoptosis rate [(21.24 +/- 5.82)%] (n = 3) did not change significantly compared to that treated with DNR alone for 24 hours [(35.73 + 6.28 )%, (22.55 +/- 3.26)%, respectively] (P > 0.05). However, HL-60 cell viability [(67.17 +/- 2.07)%] and cell apoptosis rate [(48.05 +/- 0.92)%] changed significantly in DNR plus Ara-C group compared with DNR alone [(63.31 +/- 1.80)% ,(41.51 +/- 0.89)%, respectively] (P < 0.01 and < 0.05, respectively). CONCLUSION: DNR plus Ara-C and DNR alone have similar effect on NB4 cells, but have different effect on HL-60 cells.
    [Abstract] [Full Text] [Related] [New Search]